Free Trial

Jasper Therapeutics (JSPR) Institutional Ownership

Jasper Therapeutics logo
$0.49 +0.01 (+2.37%)
Closing price 06/5/2026 04:00 PM Eastern
Extended Trading
$0.50 +0.00 (+0.67%)
As of 06/5/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Jasper Therapeutics (NASDAQ:JSPR)

Current
Institutional Ownership
Percentage
79.85%
Number of
Institutional Buyers
(last 12 months)
30
Total
Institutional Inflows
(last 12 months)
$27.00M
Number of
Institutional Sellers
(last 12 months)
10
Total
Institutional Outflows
(last 12 months)
$2.93M
Get JSPR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Jasper Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

JSPR Institutional Buying and Selling by Quarter

Jasper Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/14/2026 Renaissance Technologies LLC177,500$156K0.0%-21.9%0.634%
5/14/2026 Knott David M Jr160,789$141K0.1%-11.4%0.574%
2/19/2026 T. Rowe Price Investment Management Inc.964,754$1.77M0.0%-6.2%3.448%
2/18/2026 Sphera Funds Management LTD.485,401$888K0.2%-22.9%1.735%
2/18/2026 Quadrature Capital Ltd67,267$123K0.0%N/A0.240%
2/18/2026 Millennium Management LLC1,073,783$1.97M0.0%+194.2%3.838%
2/18/2026 Engineers Gate Manager LP14,257$26K0.0%N/A0.051%
2/18/2026 Boothbay Fund Management LLC793,954$1.45M0.0%+79.4%2.838%
2/17/2026 ADAR1 Capital Management LLC140,000$256K0.0%N/A0.500%
2/17/2026 Jain Global LLC43,301$79K0.0%N/A0.155%
2/17/2026 T. Rowe Price Investment Management Inc.385,522$706K0.0%-62.5%1.378%
2/16/2026 Squarepoint Ops LLC281,926$516K0.0%+1,919.5%1.008%
2/16/2026 Panagora Asset Management Inc.19,362$35K0.0%N/A0.069%
2/13/2026 Quarry LP99,529$182K0.0%N/A0.356%
2/12/2026 Renaissance Technologies LLC227,183$416K0.0%+9.0%0.812%
2/12/2026 Dimensional Fund Advisors LP18,664$34K0.0%-52.1%0.067%
2/12/2026 Knott David M Jr181,389$332K0.2%+5.8%0.648%
2/10/2026 Goldman Sachs Group Inc.1,746,492$3.20M0.0%+6,394.9%6.241%
2/9/2026 Geode Capital Management LLC211,857$388K0.0%+61.9%0.757%
11/17/2025 Armistice Capital LLC348,000$828K0.0%N/A2.141%
11/17/2025 Acorn Capital Advisors LLC1,382,640$3.29M1.7%N/A8.507%
11/17/2025 Woodline Partners LP1,039,751$2.48M0.0%N/A6.397%
11/17/2025 Voleon Capital Management LP20,950$50K0.0%N/A0.129%
11/17/2025 Velan Capital Investment Management LP2,668,395$6.21M5.8%+86.1%16.418%
11/17/2025 Millennium Management LLC364,939$869K0.0%+151.3%2.245%
11/17/2025 Kingdon Capital Management L.L.C.1,324,845$3.15M0.4%+93.5%8.151%
11/17/2025 Boothbay Fund Management LLC442,642$1.05M0.0%N/A2.723%
11/14/2025 Two Sigma Investments LP40,427$96K0.0%N/A0.249%
11/14/2025 Squarepoint Ops LLC13,960$33K0.0%-45.0%0.086%
11/13/2025 Knott David M Jr171,389$408K0.2%N/A1.055%
11/12/2025 Propel Bio Management LLC1,028,806$2.45M2.5%N/A6.331%
11/12/2025 Dimensional Fund Advisors LP38,963$93K0.0%-12.8%0.240%
11/7/2025 Readystate Asset Management LP98,439$234K0.0%N/A0.606%
11/7/2025Vanguard Group Inc.1,032,842$2.46M0.0%+65.4%6.356%
10/20/2025 Simplify Asset Management Inc.609,053$1.45M0.0%N/A3.748%
10/17/2025 Sowell Financial Services LLC10,400$25K0.0%-39.9%0.064%
8/19/2025 Marex Group plc13,300$74K0.0%N/A0.089%
8/15/2025 Engineers Gate Manager LP13,972$78K0.0%N/A0.093%
8/15/2025 Bank of America Corp DE293,460$1.63M0.0%-18.6%1.954%
8/14/2025 Jane Street Group LLC132,905$738K0.0%N/A0.885%
How to claim a stake in SpaceX before the June 12 IPO (Ad)

SpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in before the IPO. Jeff Brown, who identified Bitcoin, Tesla, and Nvidia before gains as high as 52,400%, 2,150%, and 32,000% respectively, is sharing the details on how to claim a stake in Elon Musk's company before it hits public markets.tc pixel

See exactly how to position yourself in SpaceX before June 12
8/13/2025 Marshall Wace LLP50,686$281K0.0%N/A0.337%
8/12/2025 XTX Topco Ltd27,348$152K0.0%N/A0.182%
8/12/2025 JPMorgan Chase & Co.65,088$361K0.0%+1,074.7%0.433%
8/8/2025 Geode Capital Management LLC131,130$728K0.0%-50.3%0.873%
8/5/2025Corton Capital Inc.10,004$56K0.1%-62.1%0.067%
8/5/2025 Bank of Montreal Can158,133$878K0.0%+120.4%1.053%
7/14/2025 Sowell Financial Services LLC17,303$96K0.0%-16.9%0.115%
6/27/2025 Goldman Sachs Group Inc.233,758$1.01M0.0%+11.2%1.556%
5/21/2025Acadian Asset Management LLC10,708$46K0.0%N/A0.071%
5/16/2025Goldman Sachs Group Inc.233,758$1.01M0.0%+11.2%1.556%
5/15/2025Kingdon Capital Management L.L.C.490,000$2.11M0.2%+9.6%3.262%
5/14/2025T. Rowe Price Investment Management Inc.702,757$3.02M0.0%+755.3%4.678%
5/12/2025Nuveen LLC102,268$440K0.0%N/A0.681%
5/9/2025Charles Schwab Investment Management Inc.26,648$115K0.0%-17.6%0.177%
5/7/2025Corton Capital Inc.26,382$113K0.4%N/A0.176%
4/17/2025Sowell Financial Services LLC20,825$90K0.0%-25.7%0.139%
3/24/2025Wellington Management Group LLP27,069$579K0.0%+13.9%0.180%
2/27/2025Jefferies Financial Group Inc.31,250$668K0.0%N/A0.208%
2/17/2025Woodline Partners LP245,676$5.25M0.0%-50.4%1.638%
2/17/2025Soleus Capital Management L.P.1,494,420$31.95M2.0%+11.2%9.962%
2/17/2025Tema Etfs LLC12,435$266K0.1%N/A0.083%
2/17/2025Stempoint Capital LP135,244$2.89M0.7%N/A0.902%
2/17/2025Integral Health Asset Management LLC650,000$13.90M1.2%+85.7%4.333%
2/17/2025Jefferies Financial Group Inc.31,250$668K0.0%N/A0.208%
2/17/2025Deutsche Bank AG170,695$3.65M0.0%+30.0%1.138%
2/17/2025Braidwell LP714,658$15.28M0.5%+47.9%4.764%
2/17/2025Bank of America Corp DE287,204$6.14M0.0%-11.9%1.915%
2/17/2025Allostery Investments LP22,000$470K0.5%N/A0.147%
2/17/2025Ally Bridge Group NY LLC122,424$2.62M2.2%-69.4%0.816%
2/14/2025Boxer Capital Management LLC350,000$7.48M0.6%N/A2.333%
2/14/2025Jane Street Group LLC10,852$232K0.0%-18.7%0.072%
2/14/2025Northern Trust Corp104,367$2.23M0.0%-2.4%0.696%
2/14/2025Propel Bio Management LLC20,000$428K0.4%N/A0.133%
2/14/2025T. Rowe Price Investment Management Inc.82,165$1.76M0.0%N/A0.548%
2/14/2025Rock Springs Capital Management LP463,088$9.90M0.4%+0.9%3.087%
2/13/2025Marshall Wace LLP77,722$1.66M0.0%+17.2%0.518%
2/13/2025Mariner LLC36,794$787K0.0%-12.8%0.245%
2/13/2025Barclays PLC18,334$392K0.0%+13.6%0.122%
2/13/2025Russell Investments Group Ltd.247,272$5.29M0.0%+16.9%1.648%
2/13/2025Wells Fargo & Company MN7,415$159K0.0%+106.7%0.049%
2/12/2025Wellington Management Group LLP27,069$579K0.0%+13.9%0.180%
2/12/2025Schroder Investment Management Group59,034$1.24M0.0%N/A0.394%
2/12/2025JPMorgan Chase & Co.5,165$110K0.0%-68.5%0.034%
2/11/2025EntryPoint Capital LLC10,431$223K0.1%N/A0.070%
2/11/2025Simplify Asset Management Inc.20,000$428K0.0%N/A0.133%
1/30/2025Rhumbline Advisers14,761$316K0.0%+12.6%0.098%
12/26/2024JPMorgan Chase & Co.16,391$308K0.0%+239.8%0.109%
11/27/2024Franklin Resources Inc.579,636$10.90M0.0%-17.0%3.864%
11/19/2024Barclays PLC16,146$304K0.0%+320.7%0.108%
11/16/2024Geode Capital Management LLC257,416$4.84M0.0%-0.9%1.704%
Your book is inside (Ad)

The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.tc pixel

11/15/2024Barclays PLC16,146$304K0.0%+320.7%0.107%
11/15/2024Jane Street Group LLC13,354$251K0.0%N/A0.088%
11/15/2024Wellington Management Group LLP23,759$447K0.0%N/A0.157%
11/15/2024State Street Corp214,883$4.04M0.0%+12.3%1.423%
11/15/2024Samsara BioCapital LLC584,642$11.00M2.1%+11.4%3.872%
11/15/2024Ikarian Capital LLC55,175$1.04M0.1%-47.5%0.365%
11/14/2024Braidwell LP483,300$9.09M0.3%N/A3.201%
11/14/2024Verition Fund Management LLC25,353$477K0.0%N/A0.168%
11/14/2024Ally Bridge Group NY LLC399,466$7.51M4.0%+82.7%2.645%
11/14/2024MetLife Investment Management LLC6,874$129K0.0%+129.1%0.046%


JSPR Institutional Ownership - Frequently Asked Questions

During the previous two years, 73 institutional investors and hedge funds held shares of Jasper Therapeutics. The most heavily invested institutionals were Soleus Capital Management L.P. ($31.95M), Braidwell LP ($15.28M), Integral Health Asset Management LLC ($13.90M), Samsara BioCapital LLC ($11.00M), Franklin Resources Inc. ($10.90M), Rock Springs Capital Management LP ($9.90M), and Boxer Capital Management LLC ($7.48M).Learn more on Jasper Therapeutics' institutional investors.

79.85% of Jasper Therapeutics' stock is owned by institutional investors. Learn more on JSPR's institutional investor holdings.

Of the 63 institutional investors that purchased Jasper Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Goldman Sachs Group Inc. ($1.77M), Acorn Capital Advisors LLC ($1.38M), Velan Capital Investment Management LP ($1.23M), Propel Bio Management LLC ($1.05M), Woodline Partners LP ($1.04M), Millennium Management LLC ($928.56K), and Boothbay Fund Management LLC ($793.95K).

Institutional investors have bought a total of 11,633,496 shares in the last 24 months. This purchase volume represents approximately $27.00M in transactions.

Of the 10 institutional investors that sold Jasper Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: T. Rowe Price Investment Management Inc. ($707.34K), Sphera Funds Management LTD. ($144.07K), Geode Capital Management LLC ($132.55K), Bank of America Corp DE ($67.23K), Renaissance Technologies LLC ($49.68K), Dimensional Fund Advisors LP ($26.00K), and Knott David M Jr ($20.60K).

Institutional investors have sold a total of 1,185,690 shares in the last 24 months. This volume of shares sold represents approximately $2.93M in transactions.



This page (NASDAQ:JSPR) was last updated on 6/6/2026 by MarketBeat.com Staff.
From Our Partners